Korean J Dermatol.  1984 Jun;22(3):263-272.

A Clinical Study of Oral Ketoconazole Therapy in Superficial Fungal Diseases: Multicenter Trials

• Song DS
• Ro BI
• Chang CY
• Kim HO
• Haw CR
• Jun JB
• Son SJ
• Youn JI
• Myung KB
• Kim JH

Abstract

Ketoconazole is one of the broad-spectrum oral antimycotic agents recently developed from imidazole derivatives. Authors performed multicenter trials to evaluate the therapeutic effect of ketoconazole in superficial fungal diseases. One hundred and eighty-four patients with superficial fungaI diseases were included in this study during 7 months from April to October, 1983 Patiets were treated with oral administration of 200 mg of ketoconazole(Nizoral) once a day for 4 weeks.-countinue-

MeSH Terms

Administration, Oral
Humans
Ketoconazole*
Ketoconazole